e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Lung disease in infants and children - ventilation, monitoring and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Relative risks of HPA axis effects for commonly prescribed corticosteroid dose regimens
P. T. Daley-Yates (Greenford, United Kingdom)
Source:
Annual Congress 2004 - Lung disease in infants and children - ventilation, monitoring and treatment
Session:
Lung disease in infants and children - ventilation, monitoring and treatment
Session type:
Thematic Poster Session
Number:
3783
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. T. Daley-Yates (Greenford, United Kingdom). Relative risks of HPA axis effects for commonly prescribed corticosteroid dose regimens. Eur Respir J 2004; 24: Suppl. 48, 3783
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Does selenium long-term therapy restore hypothalamic-pituitary-adrenal axis in oral steroids dependant patients?
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Adrenal suppression in children using inhaled corticosteroids: neither recommended nor presribed doses identify those at risk
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004
Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007
The effectiveness of inhaled steroids as first-line therapy in the treatment of newly detected asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001
The safety of LAMA/LABA combination therapy for the ocular and urinary adverse effects in the COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Expression of inflammatory cytokines following stepwise dose reduction of corticosteroids of long-term oral corticosteroids users with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 62s
Year: 2004
Budesonide/formoterol for maintenance and relief
vs.
higher dose ICS/LABA therapy: outcomes in patients symptomatic on high-dose inhaled corticosteroids (HDICS)
Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment
Year: 2007
Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
Estimation of risk of osteoporosis based on inhaled and oral corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 409s
Year: 2002
Comparison of anti-tuberculosis regimens using fixed dose combination versus single drugs
Source: Annual Congress 2010 - Prognosis of tuberculosis
Year: 2010
First line maintenance therapy for asthma: an observational study comparing inhaled corticosteroid monotherapy to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma?
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009
Hepatotoxic reactions in rats after administration of component schemes of reserve Anti-TB drugs with different safety profile
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
Adherence with two types of inhaled corticosteroids as a primary controller regimen in adult asthma patients
Source: Eur Respir J 2002; 20: Suppl. 38, 304s
Year: 2002
Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship
Source: Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019
Year: 2020
Concomitant use of low-dose inhaled corticosteroids and a long-acting bronchodilatator visavi doubling the dose of inhaled corticosterod in asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 98s
Year: 2001
Budesonide/formoterol single inhaler therapy is well tolerated and reduces systemic steroid use
Source: Eur Respir J 2004; 24: Suppl. 48, 310s
Year: 2004
The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept